NANO Nuclear Energy Bolsters its Regulatory Licensing Team with the Addition of Veteran Nuclear Professional Brent Hamilton as Director of Quality Assurance

(NASDAQ:NNE), New York, N.Y., April 01, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced the appointment Brent Hamilton as its Director of Quality Assurance. This appointment continues a series of important additions […]

GD Culture Group Limited Receives Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency

(NASDAQ:GDC), NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) — GD Culture Group Limited (“GDC” or the “Company”) (Nasdaq: GDC), and its subsidiary, AI Catalysis Corp. (“AI Catalysis”), today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) dated March 20, 2025, notifying the Company that it

Alliance Entertainment Powers Record Store Day 2025 as Premier Distributor of Exclusive Vinyl Releases

(NASDAQ:AENT), PLANTATION, Fla., April 01, 2025 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor and fulfillment partner of entertainment and pop culture collectibles, is proud to announce its pivotal role in the success of this year's upcoming Record Store Day, solidifying its position once again as the preferred partner for the

Certara Expands the Simcyp(TM) Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

(NASDAQ:CERT), RADNOR, Pa., April 01, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has released a new version of the Simcyp(TM) Simulator for physiologically-based pharmacokinetic (PBPK) modeling. Simcyp PBPK models describe and predict the behavior of drugs in different body tissues. The latest version includes numerous advancements to

NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders

(NASDAQ:XAIR), BOSTON, April 01, 2025 (GLOBE NEWSWIRE) — NeuroNOS, a pioneering biopharmaceutical company developing transformative treatments for complex neurological disorders, including Autism Spectrum Disorder (ASD), brain cancers, and Alzheimer's disease, and a subsidiary of Beyond Air (NASDAQ: XAIR), proudly announces the publication of breakthrough research by its Chief Scientific Officer, Prof. Haitham Amal, in Translational

Heritage Grocers Group Portfolio of Companies Partners with Olive Crest to Prevent Child Abuse and Neglect

ONTARIO, Calif., April 01, 2025 (GLOBE NEWSWIRE) — Heritage Grocers Group (“Heritage” or “HGG”), the largest Hispanic and ethnic food retailer in the country is pleased to announce its portfolio of companies which include Cardenas Markets, Los Altos Ranch Markets, El Rancho Supermercado, and Tony's Fresh Market, have launched in-store fundraising campaigns, in partnership with

NOVAGOLD Files First Quarter 2025 Report with Strong Treasury to Advance Donlin Gold Activities for Long-Term Value Creation

(TSX:NG),(NYSE MKT:NG), VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company”) (NYSE American, TSX: NG) today filed its 2025 first quarter report and provided an update on its Tier One1 gold development project, Donlin Gold, which NOVAGOLD owns equally with Barrick Gold Corporation (“Barrick”). Details of the financial

Brookfield Asset Management and Angel Oak to Enter into Strategic Partnership

(NYSE:BAM),(TSX:BAM),(TSX:BAM.TO),(NYSE:BAM), NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) — Brookfield Asset Management (NYSE: BAM, TSX: BAM) (“Brookfield”) and Angel Oak Companies (“Angel Oak”), a leading asset manager delivering innovative mortgage and consumer products, today announced that they have entered into an agreement in which Brookfield will acquire a majority ownership stake in Angel Oak and

Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch(TM) Bio-Hybrid Organ for Treatment of Type 1 Diabetes

(TSX:SVA),(OTC US:SEOVF),(Other OTC:SEOVF),(XETRA:PSH.DE),(Frankfurt:PSH), DSMB supports advancement for Sernova's clinical trial Study is on track to meet key clinical trial endpoints LONDON, Ontario and BOSTON, April 01, 2025 (GLOBE NEWSWIRE) — Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it's Cell Pouch Bio-hybrid Organ as a functional cure

Cypher Partners with U.S. Army 25th Infantry Division to Accelerate Military Decision Making Through AI-Agent, BATTLEMIND

ASHBURN, Va., April 01, 2025 (GLOBE NEWSWIRE) — Cypher, LLC, a leader in advanced Artificial Intelligence (AI) solutions for the national security sector, today announced it has entered into an agreement with the U.S. Army's 25th Infantry Division. This strategic partnership integrates Cypher's AI-Agent, Battlemind powered by the Guided Heuristic On-prem Support & Troubleshooting (G.H.O.S.T.)

Scroll to Top